To confirm this mechanism in the case of SIRT1, we evaluated the level of ubiquitinated SIRT1 in OxPhos-dependent DLBCL cell lines treated with HSP90 inhibitor 17AAG in the presence/absence of proteasome inhibitor MG-132 using PLA. The gene discussed is SIRT1; the disease is diffuse large B-cell lymphoma.